Revasum, Inc. Logo

Revasum, Inc.

RVS.AX

(1.2)
Stock Price

0,12 AUD

-28.48% ROA

-109.64% ROE

-1.02x PER

Market Cap.

8.328.241,40 AUD

165.95% DER

0% Yield

-41.17% NPM

Revasum, Inc. Stock Analysis

Revasum, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Revasum, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.99x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (9%), which means it has a small amount of debt compared to the ownership it holds

3 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

4 ROE

Negative ROE (-83.78%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-61.79%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Revasum, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Revasum, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Revasum, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Revasum, Inc. Revenue
Year Revenue Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1997 0 0%
1998 0 0%
2018 27.277.000 100%
2019 29.270.625 6.81%
2019 20.507.000 -42.73%
2020 15.368.000 -33.44%
2021 13.710.000 -12.09%
2022 14.749.000 7.04%
2023 28.640.704 48.5%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Revasum, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1997 0 0%
1998 0 0%
2018 3.857.000 100%
2019 5.896.375 34.59%
2019 4.131.000 -42.73%
2020 3.739.000 -10.48%
2021 3.778.000 1.03%
2022 4.101.000 7.88%
2023 10.110.424 59.44%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Revasum, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1997 0 0%
1998 0 0%
2018 4.456.000 100%
2019 10.809.306 58.78%
2019 7.573.000 -42.73%
2020 5.561.000 -36.18%
2021 4.092.000 -35.9%
2022 4.116.000 0.58%
2023 4.717.396 12.75%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Revasum, Inc. EBITDA
Year EBITDA Growth
1988 -1.548.623
1989 -275.540 -462.03%
1990 -387.501 28.89%
1991 -88.097 -339.86%
1992 -64.324 -36.96%
1993 -145.410 55.76%
1994 -534.912 72.82%
1995 -324.587 -64.8%
1997 -504.648 35.68%
1998 12.157.473 104.15%
2018 -3.761.000 423.25%
2019 -20.813.588 81.93%
2019 -11.593.000 -79.54%
2020 -4.339.000 -167.18%
2021 167.000 2698.2%
2022 -4.481.000 103.73%
2023 -8.181.128 45.23%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Revasum, Inc. Gross Profit
Year Gross Profit Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1997 0 0%
1998 0 0%
2018 10.155.000 100%
2019 3.270.054 -210.55%
2019 2.291.000 -42.73%
2020 4.888.000 53.13%
2021 4.843.000 -0.93%
2022 4.403.000 -9.99%
2023 7.323.828 39.88%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Revasum, Inc. Net Profit
Year Net Profit Growth
1988 0
1989 -318.155 100%
1990 -942.170 66.23%
1991 0 0%
1992 -39.870 100%
1993 -71.578 44.3%
1994 0 0%
1995 0 0%
1997 -1.185.724 100%
1998 4.484.586 126.44%
2018 -4.355.000 202.98%
2019 -21.333.143 79.59%
2019 -14.946.000 -42.73%
2020 -9.396.000 -59.07%
2021 -4.979.000 -88.71%
2022 -9.976.000 50.09%
2023 -10.915.176 8.6%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Revasum, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1997 0 0%
1998 0 0%
2018 -1 0%
2019 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Revasum, Inc. Free Cashflow
Year Free Cashflow Growth
1988 0
1989 0 0%
1990 0 0%
1991 -15.417 100%
1992 0 0%
1993 -382.124 100%
1994 0 0%
1995 -282.991 100%
1997 25.017 1231.19%
1998 -6.675 474.79%
2018 -6.057.000 99.89%
2019 -3.692.192 -64.05%
2019 -22.582.570 83.65%
2020 -8.496.978 -165.77%
2021 -3.111.075 -173.12%
2022 -6.609.000 52.93%
2023 -1.331.741 -396.27%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Revasum, Inc. Operating Cashflow
Year Operating Cashflow Growth
1988 0
1989 0 0%
1990 0 0%
1991 -15.417 100%
1992 0 0%
1993 -382.124 100%
1994 0 0%
1995 -282.991 100%
1997 26.879 1152.83%
1998 0 0%
2018 -4.311.000 100%
2019 0 0%
2019 -12.235.570 100%
2020 -7.978.978 -53.35%
2021 -2.959.075 -169.64%
2022 -6.567.000 54.94%
2023 -1.331.741 -393.11%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Revasum, Inc. Capital Expenditure
Year Capital Expenditure Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1997 1.862 100%
1998 6.675 72.1%
2018 1.746.000 99.62%
2019 3.692.192 52.71%
2019 10.347.000 64.32%
2020 518.000 -1897.49%
2021 152.000 -240.79%
2022 42.000 -261.9%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Revasum, Inc. Equity
Year Equity Growth
1988 2.031.721
1989 1.785.170 -13.81%
1990 562.348 -217.45%
1991 475.725 -18.21%
1992 352.450 -34.98%
1993 2.678.816 86.84%
1994 2.530.671 -5.85%
1995 2.350.527 -7.66%
1997 8.533.107 72.45%
1998 14.171.299 39.79%
2018 34.993.000 59.5%
2019 21.328.000 -64.07%
2020 11.989.999 -77.88%
2021 15.822.999 24.22%
2022 7.992.000 -97.99%
2023 7.103.123 -12.51%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Revasum, Inc. Assets
Year Assets Growth
1988 2.113.554
1989 1.799.765 -17.43%
1990 706.479 -154.75%
1991 559.968 -26.16%
1992 409.863 -36.62%
1993 2.702.487 84.83%
1994 2.544.221 -6.22%
1995 2.400.306 -6%
1997 8.568.498 71.99%
1998 16.203.169 47.12%
2018 44.206.000 63.35%
2019 32.627.000 -35.49%
2020 20.189.999 -61.6%
2021 22.541.999 10.43%
2022 18.126.000 -24.36%
2023 28.453.031 36.3%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Revasum, Inc. Liabilities
Year Liabilities Growth
1988 81.833
1989 14.594 -460.73%
1990 144.131 89.87%
1991 84.243 -71.09%
1992 57.412 -46.73%
1993 23.671 -142.54%
1994 13.550 -74.69%
1995 49.779 72.78%
1997 35.391 -40.65%
1998 2.031.868 98.26%
2018 9.213.000 77.95%
2019 11.299.000 18.46%
2020 8.200.000 -37.79%
2021 6.719.000 -22.04%
2022 10.134.000 33.7%
2023 21.349.908 52.53%

Revasum, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.19
Net Income per Share
-0.08
Price to Earning Ratio
-1.02x
Price To Sales Ratio
0.42x
POCF Ratio
-2.08
PFCF Ratio
-2.11
Price to Book Ratio
1.16
EV to Sales
0.97
EV Over EBITDA
-3.23
EV to Operating CashFlow
-4.83
EV to FreeCashFlow
-4.82
Earnings Yield
-0.99
FreeCashFlow Yield
-0.47
Market Cap
0,01 Bil.
Enterprise Value
0,02 Bil.
Graham Number
0.34
Graham NetNet
-0.1

Income Statement Metrics

Net Income per Share
-0.08
Income Quality
0.49
ROE
-1.1
Return On Assets
-0.28
Return On Capital Employed
-0.42
Net Income per EBT
1
EBT Per Ebit
1.14
Ebit per Revenue
-0.36
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0.18
Research & Developement to Revenue
0.35
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.27
Operating Profit Margin
-0.36
Pretax Profit Margin
-0.41
Net Profit Margin
-0.41

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.04
Free CashFlow per Share
-0.04
Capex to Operating CashFlow
0
Capex to Revenue
-0
Capex to Depreciation
-0.01
Return on Invested Capital
-0.38
Return on Tangible Assets
-0.28
Days Sales Outstanding
91.49
Days Payables Outstanding
125.59
Days of Inventory on Hand
329.49
Receivables Turnover
3.99
Payables Turnover
2.91
Inventory Turnover
1.11
Capex per Share
-0

Balance Sheet

Cash per Share
0,01
Book Value per Share
0,07
Tangible Book Value per Share
0.07
Shareholders Equity per Share
0.07
Interest Debt per Share
0.11
Debt to Equity
1.66
Debt to Assets
0.41
Net Debt to EBITDA
-1.82
Current Ratio
1.71
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
1.66
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
13001853
Debt to Market Cap
1.42

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Revasum, Inc. Dividends
Year Dividends Growth

Revasum, Inc. Profile

About Revasum, Inc.

Revasum, Inc. designs, develops, manufactures, and markets a portfolio of semiconductor processing equipment in North America, Asia, and Europe. The company's product portfolio includes grinding, polishing, and chemical mechanical planarization equipment used to manufacture microchips, sensors, LEDs, RF devices, and power devices, which are used in connected IoT devices, cellphones, wearables, automotive, 5G, and industrial applications. It also provides wafer processing equipment for device and substrate manufacturing. The company was incorporated in 2016 and is headquartered in San Luis Obispo, California.

CEO
Mr. Scott Jewler
Employee
106
Address
825 Buckley Road
San Luis Obispo, 93401

Revasum, Inc. Executives & BODs

Revasum, Inc. Executives & BODs
# Name Age
1 Mr. Scott Jewler
President, Chief Executive Officer & Director
70
2 Mr. Bruce G. Ray
Chief Financial Officer & Company Secretary
70
3 Mr. Alejandro Garcia
Chief Operating Officer
70
4 Dr. Karey Holland Ph.D.
Chief Technology Officer
70
5 Mr. Chris Sloan
Vice President of Worldwide Sales & Marketing
70

Revasum, Inc. Competitors

4DS Memory Limited Logo
4DS Memory Limited

4DS.AX

(0.8)
BluGlass Limited Logo
BluGlass Limited

BLG.AX

(0.5)
Weebit Nano Limited Logo
Weebit Nano Limited

WBT.AX

(0.8)
Xref Limited Logo
Xref Limited

XF1.AX

(1.5)